| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 5.70M | — |
| Operating expense | — | — |
| Net income | -13.92M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PRLD returned +434.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +128.6% |
| 1 year | +434.7% |
| 5 years | -81.4% |
| All-time high | $71.55 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PRLD would be worth today ›No. Prelude Therapeutics Incorporated has not paid a dividend in the past 12 months.
Prelude Therapeutics Incorporated stock trades on NASDAQ under the ticker symbol PRLD.
Prelude Therapeutics Incorporated is part of the Healthcare sector.
Prelude Therapeutics Incorporated has a market cap of 529.10M USD, based on the latest quote.
Prelude Therapeutics Incorporated is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
